What is Ketryx?
Ketryx operates at the intersection of artificial intelligence and regulatory compliance, providing a specialized platform designed to transform the product lifecycle for life science teams. By overlaying existing development tools, the company automates documentation and ensures traceability, which is essential for maintaining safety standards in medical device production. Currently trusted by three of the world's top five medical device manufacturers, Ketryx addresses the industry's critical need to accelerate release cycles without compromising on quality or compliance. Its market position is defined by its ability to integrate seamlessly into established workflows, effectively reducing the friction typically associated with rigorous medical device certification processes.
How much funding has Ketryx raised?
Ketryx has raised a total of $89.1M across 3 funding rounds:
Series A
$14M
Series B
$39M
Stock/Share Issuance
$36.1M
Series A (2023): $14M with participation from Lightspeed Venture Partners, Ubiquity Ventures, and E14 Fund
Series B (2025): $39M led by MIT, Ubiquity Ventures, Transformation Capital, and Lightspeed Venture Partners
Stock/Share Issuance (2025): $36.1M, investors not publicly disclosed
Key Investors in Ketryx
Lightspeed Venture Partners
A global multistage venture capital firm that invests in early and growth-stage technology companies across sectors such as enterprise software, fintech, and infrastructure.
Ubiquity Ventures
A seed-stage institutional venture capital firm specializing in software beyond the screen, focusing on smart hardware and machine intelligence.
Transformation Capital
A growth equity fund headquartered in Boston, fully dedicated to investing in innovative healthcare IT and services companies.
What's next for Ketryx?
With this latest capital injection, Ketryx is poised to scale its operations and further enhance its AI-driven compliance suite. The strategic focus will likely center on expanding its footprint among global medical device leaders and deepening the platform's integration capabilities. As the regulatory landscape for digital health and medical technology continues to evolve, Ketryx's ability to provide automated, audit-ready documentation will remain a key competitive advantage. The company is expected to leverage these resources to accelerate product development, potentially exploring new verticals within the broader life sciences ecosystem where compliance-heavy workflows remain a bottleneck for innovation.
See full Ketryx company page
